Loading...
XNYSSTE
Market cap20bUSD
Dec 20, Last price  
207.49USD
1D
1.54%
1Q
-12.44%
Jan 2017
207.89%
IPO
174.78%
Name

STERIS plc

Chart & Performance

D1W1MN
XNYS:STE chart
P/E
54.15
P/S
3.99
EPS
3.83
Div Yield, %
0.98%
Shrs. gr., 5y
3.06%
Rev. gr., 5y
13.06%
Revenues
5.14b
+3.65%
1,119,745,0001,160,285,0001,197,407,0001,265,090,0001,298,525,0001,257,733,0001,207,448,0001,391,504,0001,501,902,0001,622,252,0001,850,263,0002,238,764,0002,612,756,0002,619,996,0002,782,170,0003,030,895,0003,107,519,0004,585,064,0004,957,839,0005,138,701,000
Net income
378m
+253.40%
85,980,00070,289,00082,155,00077,106,000110,685,000128,467,00051,265,000136,115,000159,977,000129,442,000135,064,000110,763,000109,965,000290,915,000304,051,000407,659,000397,400,000243,888,000107,030,000378,239,000
CFO
973m
+28.58%
151,389,000161,955,00095,740,000143,401,000167,384,000224,954,000117,744,000149,372,000227,815,000209,631,000246,040,000254,675,000424,086,000457,632,000539,505,000590,559,000689,640,000684,811,000756,947,000973,274,000
Dividend
Sep 05, 20240.57 USD/sh
Earnings
Feb 05, 2025

Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
URL
https://www.steris.com/
IPO date
Nov 03, 2015
Employees
17,000
Domiciled in
IE
Incorporated in
IE

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
5,138,701
3.65%
4,957,839
8.13%
4,585,064
47.55%
Cost of revenue
4,251,012
4,198,604
4,159,398
Unusual Expense (Income)
NOPBT
887,689
759,235
425,666
NOPBT Margin
17.27%
15.31%
9.28%
Operating Taxes
149,530
51,535
71,633
Tax Rate
16.84%
6.79%
16.83%
NOPAT
738,159
707,700
354,033
Net income
378,239
253.40%
107,030
-56.12%
243,888
-38.63%
Dividends
(200,570)
(183,498)
(163,169)
Dividend yield
0.90%
0.96%
0.69%
Proceeds from repurchase of equity
(11,765)
(308,565)
(45,706)
BB yield
0.05%
1.61%
0.19%
Debt
Debt current
117,177
90,065
179,347
Long-term debt
3,443,057
3,359,937
3,137,009
Deferred revenue
Other long-term liabilities
551,234
88,572
259,640
Net debt
3,353,214
3,241,645
2,959,907
Cash flow
Cash from operating activities
973,274
756,947
684,811
CAPEX
(360,326)
(361,969)
(287,563)
Cash from investing activities
(887,361)
(383,330)
(666,559)
Cash from financing activities
(85,186)
(498,718)
115,830
FCF
(90,852)
265,395
(353,206)
Balance
Cash
207,020
208,357
348,320
Long term investments
8,129
Excess cash
127,196
Stockholders' equity
6,315,346
6,087,172
6,544,637
Invested Capital
10,249,747
9,340,239
9,775,036
ROIC
7.54%
7.40%
4.58%
ROCE
8.66%
7.62%
3.98%
EV
Common stock shares outstanding
99,359
100,246
98,326
Price
224.82
17.53%
191.28
-20.88%
241.77
26.93%
Market cap
22,337,890
16.49%
19,175,055
-19.34%
23,772,277
45.29%
EV
25,704,286
22,426,674
26,744,465
EBITDA
887,689
1,312,132
978,770
EV/EBITDA
28.96
17.09
27.32
Interest
144,351
109,620
89,593
Interest/NOPBT
16.26%
14.44%
21.05%